
Sign up to save your podcasts
Or
This week, please join author Brendon Neuen and Editor Sandeep Das as they discuss the original research article "Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20240205.184727
4.3
3030 ratings
This week, please join author Brendon Neuen and Editor Sandeep Das as they discuss the original research article "Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20240205.184727
133 Listeners
315 Listeners
165 Listeners
861 Listeners
489 Listeners
19 Listeners
277 Listeners
91 Listeners
136 Listeners
58 Listeners
191 Listeners
349 Listeners
18 Listeners
250 Listeners
426 Listeners